Small-colony variant selection as a survival strategy for Staphylococcus aureus in the presence of Pseudomonas aeruginosa

Applied and Environmental Microbiology

Volumn 75, Issue 21, 2009, Pages 6910-6912

  Biswas, Lalitha ^a   Biswas, Raja ^a   Schlag, Martin ^a   Bertram, Ralph ^a   Götz, Friedrich ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CO-CULTIVATION; ELECTRON TRANSPORT CHAIN; P.AERUGINOSA; PSEUDOMONAS AERUGINOSA; PYOCYANIN; S. AUREUS; STAPHYLOCOCCUS AUREUS; VARIANT SELECTION;

ENZYME INHIBITION;

CYANIDE; GREEN FLUORESCENT PROTEIN; PHENAZINE; PYOCYANINE; RED FLUORESCENT PROTEIN;

BACTERIUM; COLONY STRUCTURE; HABITAT SELECTION; MUTATION; PATHOGENICITY; PHENOTYPE; SURVIVORSHIP;

ARTICLE; BACTERIAL SURVIVAL; BACTERIUM CULTURE; BIOFILM; COCULTURE; DISK DIFFUSION; ELECTRON TRANSPORT; GENETIC VARIABILITY; MUTANT; NONHUMAN; PHENOTYPE; PROTEIN PURIFICATION; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

ANTIBIOSIS; MICROBIAL VIABILITY; PSEUDOMONAS AERUGINOSA; PYOCYANINE; STAPHYLOCOCCUS AUREUS; STRESS, PHYSIOLOGICAL;

PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 70350515973     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.01211-09     Document Type: Article

References (18)

1. Burns, J. L., J. Emerson, J. R. Stapp, D. L. Yim, J. Krzewinski, L. Louden, B. W. Ramsey, and C. R. Clausen. 1998. Microbiology of sputum from patients at cystic fibrosis centers in the United States. Clin. Infect. Dis. 27:158-163.
2. Castric, P. A. 1975. Hydrogen cyanide, a secondary metabolite of Pseudomonas aeruginosa. Can. J. Microbiol. 21:613-618.
3. Clauditz, A., A. Resch, K. P. Wieland, A. Peschel, and F. Götz. 2006. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress. Infect. Immun. 74:4950-4953.
4. Cox, C. D. 1986. Role of pyocyanin in the acquisition of iron from transferrin. Infect. Immun. 52:263-270.
5. Hassan, H. M., and I. Fridovich. 1980. Mechanism of the antibiotic action pyocyanine. J. Bacteriol. 141:156-163.
6. Hoffman, L. R., E. Deziel, D. A. D'Argenio, F. Lepine, J. Emerson, S. Mc-Namara, R. L. Gibson, B. W. Ramsey, and S. I. Miller. 2006. Selection for Staphylococcus aureus small-colony variants due to growth in the presence of Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 103:19890-19895.
7. Kogut, M., and J. W. Lightbown. 1962. Selective inhibition by 2-heptyl-4-hydroxyquinoline N-oxide of certain oxidation-reduction reactions. Biochem. J. 84:368-382.
8. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
9. Machan, Z. A., G. W. Taylor, T. L. Pitt, P. J. Cole, and R. Wilson. 1992. 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J. Antimicrob. Chemother. 30:615-623.
10. Marks, M. I. 1990. Clinical significance of Staphylococcus aureus in cystic fibrosis. Infection 18:53-56.
11. McNamara, P. J., and R. A. Proctor. 2000. Staphylococcus aureus small colony variants, electron transport and persistent infections. Int. J. Antimicrob. Agents 14:117-122.
12. Pelz, A., K. P. Wieland, K. Putzbach, P. Hentschel, K. Albert, and F. Götz. 2005. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus. J. Biol. Chem. 280:32493-32498.
13. Proctor, R. A., P. van Langevelde, M. Kristjansson, J. N. Maslow, and R. D. Arbeit. 1995. Persistent and relapsing infections associated with small-colony variants of Staphylococcus aureus. Clin. Infect. Dis. 20:95-102.
14. Proctor, R. A., C. von Eiff, B. C. Kahl, K. Becker, P. McNamara, M. Herrmann, and G. Peters. 2006. Small colony variants: a pathogenic form of bacteria that facilitates persistent and recurrent infections. Nat. Rev. Microbiol. 4:295-305.
15. Reimmann, C., M. Beyeler, A. Latifi, H. Winteler, M. Foglino, A. Lazdunski, and D. Haas. 1997. The global activator GacA of Pseudomonas aeruginosa PAO1 positively controls the production of the autoinducer N-butyryl-homoserine lactone and the formation of the virulence factors pyocyanin, cyanide, and lipase. Mol. Microbiol. 24:309-319.
16. Rubio, T. T. 1986. Infection in patients with cystic fibrosis. Am. J. Med. 81:73-77.
17. Voggu, L., S. Schlag, R. Biswas, R. Rosenstein, C. Rausch, and F. Götz. 2006. Microevolution of cytochrome bd oxidase in staphylococci and its implication in resistance to respiratory toxins released by Pseudomonas. J. Bacteriol. 188:8079-8086. (Pubitemid 44845677)
18. von Eiff, C., C. Heilmann, R. A. Proctor, C. Woltz, G. Peters, and F. Götz. 1997. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly. J. Bacteriol. 179:4706-4712.